Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy
V. D. de Jager, P. Plomp, M. S. Paats, S. van Helvert, A. ter Elst, A. van den Berg, H. J. Dubbink, W. H. van Geffen, L. Zhang, L. E.L. Hendriks, T. J.N. Hiltermann, B. I. Hiddinga, L. B.M. Hijmering-Kappelle, M. Jalving, J. Kluiver, B. Koopman, M. van Kruchten, E. M.J. van der Logt, B. Piet, J. van PuttenB. H. Reitsma, S. R. Rutgers, M. de Vries, J. A. Stigt, M. R. Groves, W. Timens, S. M. Willems, L. C. van Kempen, E. Schuuring*, A. J. van der Wekken*
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy'. Together they form a unique fingerprint.